| ||
| Lilly, Bristol-Myers halt drug study enrollment Bloomberg ... with Lilly's cancer treatment Alimta and the standard chemotherapy cisplatin as an initial treatment for advanced non-small cell lung cancer. ... See all stories on this topic » |
| ||
| QGEN, CTIC, APCVZ - Notable Stocks at NASDAQ Healthcare Sector by ... Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for the treatment of cancer. It is developing pixantrone, a Phase III single-agent clinical trial product for the treatment of ... and immunological disorders; OPAXIO, a Phase III clinical trial product for the treatment of ovarian, esophageal, and non-small cell lung cancer; and brostallicin, a Phase I/II clinical trials product for the treatment of sarcoma. ... Transportation - http://transportation.stockhottips.com/ |
| ||
| Weed's Sap Skin Cancer Treatment: Pharma Int. News Lung Cancer Deaths. Breast cancer drug treatment Tamoxifen could viably benefit lung cancer patients, says new Swiss study ... www.pharmaceutical-int.com/.../weeds-sap-is-potential-skin-ca... | ||
| New Test May Help Guide Prostate Cancer Treatment « CBS Dallas ... New Test May Help Guide Prostate Cancer Treatment. February 2, 2011 2:48 PM. Print Share 0 .... Lung Cancer · Physical Therapy · Alzheimer's Disease ... dfw.cbslocal.com/.../new-test-may-help-guide-prostate-cancer-... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment